During treatment with GnRH analogs, a number of patients experience gastrointestinal side effects, with a small percentage developing severe complications such as chronic intestinal pseudo-obstruction (CIPO) or enteric dysmotility (ED). Here, GNRH1 is linked to chronic intestinal pseudoobstruction.